Progression of disease within 24 months (POD24) in follicular lymphoma in the rituximab era: incidence, clinicopathological risk factors, and outcome in a population-based Danish cohort

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Blood cancer journal (New York) 2024-09, Vol.14 (1), p.167-4, Article 167
Hauptverfasser:	Enemark, Marie Hairing, Hemmingsen, Jonas Klejs, Andersen, Maja Dam, Hybel, Trine Engelbrecht, Bjørn, Mads Emil, Josefsson, Pär Lars, Pedersen, Lars Møller, Juul, Maja Bech, Pedersen, Robert Schou, Thorsgaard, Michael, Sillesen, Ida Blok, Plesner, Trine Lindhardt, Hamilton-Dutoit, Stephen Jacques, Jensen, Paw, Madsen, Charlotte, Ludvigsen, Maja
Format:	Artikel
Sprache:	eng
Schlagworte:	692/499 692/699/67/1990/291/1621/1915 Adult Aged Aged, 80 and over Biomedical and Life Sciences Biomedicine Cancer Research Cohort Studies Correspondence Denmark - epidemiology Disease Progression Female Hematology Humans Incidence Lymphoma, Follicular - drug therapy Lymphoma, Follicular - epidemiology Lymphoma, Follicular - pathology Male Middle Aged Oncology Risk Factors Rituximab - therapeutic use Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!